Hanna Eilken

About

Experience

• Alliance Manager at Boehringer Ingelheim
  Nov 2024 - Present · 1 yr 8 mos

• Bayer (11 yrs 2 mos)
  • Early Stage Alliance Manager, BD&L TA New Platforms, Cardiovascular, and Immunology
    Nov 2022 - Oct 2024 · 2 yrs

  • Early Stage Alliance Manager, BD&L TA New Platforms/OPH/HEM
    May 2022 - Oct 2022 · 6 mos

  • Strategic Alliance Manager
    Jun 2018 - Jun 2022 · 4 yrs 1 mo

    Alliance management of the Bayer - Broad Cardiovascular collaboration

• Postdoctoral Scientist at Max-Planck Institute for molecular Biomedicine
  Nov 2008 - May 2013 · 4 yrs 7 mos

  Study the role of pericytes in angiogenesis in vivo in the lab of Prof. Dr. Ralf Adams • Characterize novel transgenic mouse lines to genetically modify pericytes in vivo • Loss of function studies to specifically address the involvement of pericytes in the development of the mouse retinal vasculature • Perform initial in vivo studies to visualize and ablate pericytes in the mouse brain and heart Selected publications: • Eilken HM, Diéguez-Hurtado R, Schmidt I, Nakayama M, Jeong HW, Arf H, Adams S, Ferrara N, Adams RH (2017): Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1. Nature Communications, 8(1), 1574 • Eilken HM, Adams RH (2010): Dynamics of endothelial cell behavior in sprouting angiogenesis. (Review) Current Opinion in Cell Biology, 22(5), 617-625

• Postdoctoral Scientist at HelmholtzZentrum München
  Aug 2008 - Oct 2008 · 3 mos